Cipla receives final approval for generic Wellbutrin XL tablets
They are indicated for the treatment of major depressive disorder (MDD) and prevention of seasonal affective disorder (SAD)
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Home » Latest Updates » Page 296
Browsing Category
Latest Updates
DPCO for 350 drugs to be amended in 15 days: Ananth Kumar
The minister also launched a new mobile app, ‘Pharma Sahi Daam’ to help customers to know the prices of medicines fixed by the…
DRL launches nitroglycerin sublingual tablets in the US market
The Nitrostat (nitroglycerin) sublingual tablet brand had US sales of approximately $108 million MAT for the most recent twelve…
Shimadzu Corp launches new ICPMS 2030 in India
It is designed to help comply with USP 232/233 and ICH* Q3D guidelines for elemental impurities in pharma products
Shimadzu…
US FDA warns former Sun Pharma US drug factory over quality concerns
This is one of a series of quality concerns tied to the Philadelphia, Pennsylvania factory that the FDA highlighted in an August…
Lupin receives tentative approval for generic Paxil CR tabs
It is indicated for the treatment of major depressive disorder, panic disorder, social anxiety disorder and premenstrual dysphoric…
AYUSH ministry and USP sign MoU
To promote safety, quality and integrity of traditional medicines
EMA to review Mylan and Biocon’s regulatory submission for proposed biosimilar Trastuzumab
This is the second biosimilar submission developed by the partnership that has been accepted for review in Europe
Strides Shasun receives USFDA approval for Polyethylene Glycol 3350, Powder for Solution (OTC)
The product will be launched in Q4 FY 2017, in line with the OTC procurement cycle in the market
BGR-34 is scientifically validated and highly effective in type 2 diabetes management: Shripad Naik
Naik also informed that research has been going on to develop and scientifically validate other herbal medicines to address other…